Qualitative and Quantitative Detection of Runt-Related Transcription Factor 1 and Eight-Twenty-One Oncoprotein Gene Fusion Products using Thermal Fingerprint and Cycle Threshold Value by Employing a DNA Intercalating Dye and Fluorescent PCR for Detecting Acute Myeloid Leukaemia (AML)_Crimson Publishers

 

Qualitative and Quantitative Detection of Runt-Related Transcription Factor 1 and Eight-Twenty-One Oncoprotein Gene Fusion Products using Thermal Fingerprint and Cycle Threshold Value by Employing a DNA Intercalating Dye and Fluorescent PCR for Detecting Acute Myeloid Leukaemia (AML) by Pratap Mukhopadhyaya 

in Novel Approaches in Cancer Study

Abstract

An intercalating dye-based qualitative and quantitative real time PCR assay was developed to detect and estimate the AML1/ETO fusion transcript in patients suffering from Acute myeloid leukaemia. Quantitation standard was prepared by molecular cloning of the fusion transcript in a multicopy cloning vector followed by its propagation in Escherichia coli. Nucleotide sequencing confirmed the AML1/ETO fusion point within the cloned insert and further, its serial dilution resulted in a predicted increase in cycle threshold value which was used to generate a standard curve. Secondary calibration of the standard with an CE-IVD approved, quantified control DNA allowed quantitative detection of AML1/ETO and ABL copy numbers of an AML1/ETO testing panel of samples and the percentage of the AML1/ETO was successfully ascertained. Qualitative detection data of the fusion transcripts from the panel indicated 100% concordance of data when compared with a published protocol that used hydrolysis probes (TaqMan) for detecting the AML1/ETO fusion transcript percentage in clinical samples. The study indicated the potential of using Evagreen as an intercalating dye for qualitative and quantitative detection of AML1/ETO and ABL transcripts for estimating Minimal Residual Disease (MRD) in AML patients.

 

Read more about this article:

https://crimsonpublishers.com/nacs/fulltext/NACS.000671.php

For more articles in Novel Approaches in Cancer Study

https://crimsonpublishers.com/nacs/


Comments

Post a Comment

Popular posts from this blog

Recent Advances in the Therapeutic Approaches of Glioblastoma Multiforme_Crimson Publishers

Image
  Recent Advances in the Therapeutic Approaches of Glioblastoma Multiforme by Siddharth Shah in  in Novel Approaches in Cancer Study Abstract Glioblastoma Multiforme (GBM, WHO grade IV) is one of the most aggressive, invasive, and lethal intracranial neoplasms, with a low post-diagnosis survival rate. Standard-of-care treatment regimens involving maximal surgical resection, radiotherapy, and genetic anti-tumor compounds like Temozolomide have only been marginally effective in improving overall survival and quality of life. Cell fusion, autophagy, and other complex biological processes affecting GBM pathophysiology are being studied to improve GBM treatment. This paper therefore focuses on oncolytic virus therapy combined with surgical resection, photodynamic therapy, and novel gene therapy, demonstrating how GBM treatment for patients could result in immediate and authentic tumor cytotoxicity and removal, rather than treatment of recurrent GBM. Standard therapy for GBM,...
Read more

Release of Inorganic Phosphate into the Tumor Environment: Possible Roles of Ecto- Nucleotidases and Ecto-Phosphatases

Abstract Inorganic phosphate (Pi) is essential for several biochemical reaction. Serum Pi is maintained at relatively narrow range concentrations, between 0.7 and 1.55mM. Tumor microenvironment presents a high Pi concentration (1.8±0.2mM Pi) and this could be associated wi the rapid growth in the “Growth Rate Hypothesis”. Several studies have identified high expression of Pi transporters in various tumor tissues. Similarly, ecto-enzymes (like ecto-nucleotidases or ecto- phosphates) act by dephosphorylating phosphosubstrates in the extracellular environment, and its high expression has been observed in various types of cancer. Little is known about the function of these ecto-enzymes on Pi releasing and accumulation in the tumor environment. Therefore, the purpose of this study is to correlate a possible contribution of the Pi release in the tumor microenvironment by ecto-nucleotidases and ecto-phosphatases, concomitant to the regulation of Pi extracellular pool by specific Pi...
Read more

Release of Inorganic Phosphate into the Tumor Environment: Possible Roles of Ecto- Nucleotidases and Ecto-Phosphatases_Crimson Publishers

Image
Release of Inorganic Phosphate into the Tumor Environment: Possible Roles of Ecto- Nucleotidases and Ecto-Phosphatases by Marco Antonio Lacerda-Abreu and José Roberto Meyer- Fernandes in Journal of Cancer Research Crimson Publishers _  Novel Approaches in Cancer Study Inorganic phosphate (Pi) is essential for several biochemical reaction. Serum Pi is maintained at relatively narrow range concentrations, between 0.7 and 1.55mM. Tumor microenvironment presents a high Pi concentration (1.8±0.2mM Pi) and this could be associated wi the rapid growth in the “Growth Rate Hypothesis”. Several studies have identified high expression of Pi transporters in various tumor tissues. Similarly, ecto-enzymes (like ecto-nucleotidases or ecto- phosphates) act by dephosphorylating phosphosubstrates in the extracellular environment, and its high expression has been observed in various types of cancer. Little is known about the function of these ecto-enzymes on Pi releasing and accumulation in the tu...
Read more